Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.87 and traded as low as $0.53. Pharma-Bio Serv shares last traded at $0.53, with a volume of 6,390 shares changing hands.
Pharma-Bio Serv Stock Performance
The stock has a fifty day simple moving average of $0.71 and a 200-day simple moving average of $0.86. The stock has a market cap of $12.08 million, a price-to-earnings ratio of 17.54 and a beta of 0.53.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last announced its quarterly earnings data on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.03). Pharma-Bio Serv had a return on equity of 3.95% and a net margin of 4.05%. The company had revenue of $2.38 million during the quarter, compared to analyst estimates of $5.00 million. Sell-side analysts forecast that Pharma-Bio Serv, Inc. will post 0.08 earnings per share for the current fiscal year.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
See Also
- Five stocks we like better than Pharma-Bio Serv
- Ride Out The Recession With These Dividend Kings
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- What is the Dow Jones Industrial Average (DJIA)?
- Adobe Stock: It’s Not Too Late To Buy The Dip
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.